Word: maker
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...portable "vacation home," a tent that sleeps five and includes a screen porch ($499); or the Coleman Company's "Event Center," a 40 1/2-in. collapsible bar with a 37-qt. storage compartment roomy enough for a case of Chardonnay ($29.99); or for the Starbucks-deprived, G.S.I. Outdoors' Mini-Expresso maker, which weighs in at a featherlight...
...some point too the motive and the forces of motiveless malignity converge; it doesn't matter whether an explosion is touched off by a fanatic or a mischief maker--the cause is buried by the effect. A bomb is like the physical equivalent of an insinuation--an anonymous, handwritten note that says, "Just when you thought you were safe..." Terror now lurks in the shadows like a stranger in a dark ramp behind the parade of nations...
Even the loftiest highflyers have been losing altitude fast. Shares of Netscape, maker of the Navigator Web browser, which opened at $14 last August (after adjusting for a two-for-one split) and peaked in December at $87, closed last week at $48.50. Yahoo!, a vaunted search-engine-software company, jumped from $13 per share to $32.25 when it began trading in April and soon hit a high of $43. Last Friday, however, Yahoo! was searching for the bottom, at $17.50. "The IPOs that came with the most sizzle, like the Internet search engines, have gone on a roller-coaster...
Just ask disappointed executives of American Pad & Paper, a $275 million maker of office supplies in Dallas that went public earlier this month at an initial price of $15 per share. Investors hoped to make a quick buck on this well-established company. But instead of taking off, the stock sputtered 13 cents higher during its first day of trading before settling back to its opening price. It closed last week at $14 per share...
Recent high-tech start-ups have fared even worse. A Houston, Pennsylvania, software maker called ANSYS opened at $13 per share on June 20, only to finish the day at $12 per share. ANSYS closed Friday at $12.37. New medical companies have been hit just as hard. CollaGenex Pharmaceuticals, a California dental-research firm, tried to lure investors last month by lowering the price of its IPO to $10 per share, well below the high of $15 originally projected. It didn't work: CollaGenex stumbled on its first day of trading, to $8.63 per share...